U.S. FDA· @FDA · X·· 26 天前AI 评分22
AI 导读
提醒:FDA将于10月28日下午1点至5点(美东时间)举行混合会议,就罕见病框架倡议征求各方意见,该倡议旨在重新构想FDA对罕见病药物开发的监管方式。了解如何注册:https://www.fda.gov/news-events/fda-meetings-conferences-and-workshops/fda-rare-disease-framework-initiative-public-meeting-10282026
正文
Reminder: FDA is holding a hybrid meeting on Oct. 28 from 1-5 pm ET to seek input on its Rare Disease Framework Initiative reimagining the agency’s approach to rare disease drug development. Find out how to register: https://www.fda.gov/news-events/fda-meetings-conferences-and-workshops/fda-rare-disease-framework-initiative-public-meeting-10282026
来源:U.S. FDA · x.com